Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TBCRC 019: An open label, randomized, phase II trial of nanoparticle albumin-bound paclitaxel (nab-PAC) with or without the anti-death receptor 5 (DR5) monoclonal antibody tigatuzumab (TIG) in patients with metastatic triple negative breast cancer (TNBC)
    Meeting Abstract

    Vakiavas, C.; Abramson, V. G.; Lin, N. U.; Liu, M. C.; Rugo, H. S.; Nanda, R.; Storniolo, A. M.; Traina, T. A.; Li, Y.; Patil, S.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Comparison of doxorubicin and cyclophosphamide (AC) versus single-agent paclitaxel (T) as adjuvant therapy for breast cancer in women with 0-3 positive axillary nodes: CALGB 40101
    Meeting Abstract

    Shulman, L. N.; Berry, D. A.; Cirrincione, C. T.; Becker, H.; Perez, E. A.; O'Regan, R.; Martino, S.; Shapiro, C. L.; Atkins, J.; Schneider, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Genome sequencing of multiple primary tumors to reveal underlying germline cancer susceptibility
    Meeting Abstract

    Schrader, K. A.; Stratton, K. L.; Murali, R.; Laitman, Y.; Cavallone, L.; Offit, L.; Wen, Y. H.; Shah, S.; Rau-Murthy, R.; Manschreck, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Biomarker prediction of chemotherapy-related amenorrhea
    Meeting Abstract

    Ruddy, K. J.; O'Neill, A. M.; Miller, K.; Schneider, B. P.; Baker, E.; Sparano, J. A.; Dang, C. T.; Northfelt, D. W.; Sledge, G. W.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Needs assessment and utilization of an educational workshop and support group for Lynch syndrome patients
    Meeting Abstract

    Rau-Murthy, R.; Anrig, C.; Glogowski, E.; Salo-Mullen, E. E.; Fleischut, M. H.; Sarrel, K.; Corines, M.; Niehaus, K.; Robson, M. E.; Markowitz, A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Differences in psychosocial factors among diverse women enrolled in a phase III cooperative group metastatic breast cancer trial (CALGB 40502/Alliance)
    Meeting Abstract

    Polite, B. N.; Allred, J. B.; Rugo, H. S.; Cipriano, T. M.; Cirrincione, C.; Gehlert, S. J.; Paskett, E. D.; Hudis, C.; Winer, E. P.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Does biomarker information impact patients' preferences for therapy?
    Meeting Abstract

    Partridge, A. H.; Sepucha, K.; O'Neill, A.; Miller, K.; Baker, E.; Dang, C. T.; Northfelt, D. W.; Sledge, G. W.; Schneider, B. P.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Predictors of adequate financial resources 5 years after breast cancer diagnosis in low-income women
    Meeting Abstract

    Patil, S.; Blinder, V. S.; Gany, F.; Maly, R. C.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Randomized phase II study of gemcitabine (G), cisplatin (C) with or without veliparib (V) (arms A, B) and a phase II single-arm study of single-agent veliparib (arm C) in patients with BRCA or PALB2-mutated pancreas adenocarcinoma (PC)
    Meeting Abstract

    O'Reilly, E. M.; Lowery, M. A.; Yu, K. H.; Capanu, M.; Stadler, Z. K.; Epstein, A. S.; Golan, T.; Segal, A.; Segal, M.; Salo-Mullen, E. E.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Impact of neoadjuvant chemotherapy plus HER2-targeting on breast conservation rates: Surgical results from CALGB 40601 (Alliance)
    Meeting Abstract

    Ollila, D. W.; Berry, D. A.; Cirrincione, C.; Carey, L. A.; Amos, K. D.; Henry, N. L.; Winer, E. P.; Hudis, C.; Golshan, M.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save